Growth Metrics

Entera Bio (ENTX) Short term Debt (2020 - 2021)

Entera Bio has reported Short term Debt over the past 2 years, most recently at $698000.0 for Q3 2021.

  • For the quarter ending Q3 2021, Short term Debt changed N/A year-over-year to $698000.0, compared with a TTM value of $698000.0 through Sep 2021, changed N/A, and an annual FY2020 reading of $1.4 million, changed N/A over the prior year.
  • Short term Debt came in at $698000.0 for Q3 2021, down from $1.4 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $8.5 million in Q1 2021 to a low of $698000.0 in Q3 2021.